Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24748443)

1.

Association between vitamin D status and COPD phenotypes.

Moberg M, Ringbaek T, Roberts NB, Vestbo J.

Lung. 2014 Aug;192(4):493-7. doi: 10.1007/s00408-014-9582-9. Epub 2014 Apr 20.

PMID:
24748443
2.

Relationship between vitamin D and lung function, physical performance and balance on patients with stage I-III chronic obstructive pulmonary disease.

Yumrutepe T, Aytemur ZA, Baysal O, Taskapan H, Taskapan CM, Hacievliyagil SS.

Rev Assoc Med Bras. 2015 Mar-Apr;61(2):132-8. doi: 10.1590/1806-9282.61.02.132.

3.

Erratum: Bioactive Lipids in Emphysema: Decoding Fat to Reveal COPD Phenotypes.

[No authors listed]

Am J Respir Crit Care Med. 2015 May 15;191(10):1210. doi: 10.1164/rccm.19110erratum1. No abstract available.

PMID:
25978580
4.

Error occurred: cannot get document summary

PMID:
25942956

5.

Relationship of vitamin D status with lung function and exercise capacity in COPD.

Jung JY, Kim YS, Kim SK, Kim HY, Oh YM, Lee SM, Seo JB, Lee SD; KOLD Study.

Respirology. 2015 Jul;20(5):782-9. doi: 10.1111/resp.12538. Epub 2015 Apr 13.

PMID:
25868752
6.

Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD.

Persson LJ, Aanerud M, Hiemstra PS, Michelsen AE, Ueland T, Hardie JA, Aukrust P, Bakke PS, Eagan TM.

PLoS One. 2015 Mar 24;10(3):e0121622. doi: 10.1371/journal.pone.0121622. eCollection 2015.

7.

Innate immune modulation in chronic obstructive pulmonary disease: moving closer toward vitamin D therapy.

Heulens N, Korf H, Janssens W.

J Pharmacol Exp Ther. 2015 May;353(2):360-8. doi: 10.1124/jpet.115.223032. Epub 2015 Mar 9. Review.

PMID:
25755208
8.

Bioactive lipids in emphysema. Decoding fat to reveal COPD phenotypes.

Mirzaie M, Kheradmand F.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):241-3. doi: 10.1164/rccm.201412-2264ED. No abstract available.

PMID:
25635483
9.

Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients.

Malinovschi A, Masoero M, Bellocchia M, Ciuffreda A, Solidoro P, Mattei A, Mercante L, Heffler E, Rolla G, Bucca C.

Respir Res. 2014 Dec 13;15:131. doi: 10.1186/s12931-014-0131-0.

10.

Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.

Bowler RP, Jacobson S, Cruickshank C, Hughes GJ, Siska C, Ory DS, Petrache I, Schaffer JE, Reisdorph N, Kechris K.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):275-84. doi: 10.1164/rccm.201410-1771OC.

PMID:
25494452
11.

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluña JJ, Garcia-Lujan R, Ribera X.

Int J Chron Obstruct Pulmon Dis. 2014 Nov 19;9:1307-14. doi: 10.2147/COPD.S71849. eCollection 2014.

12.

Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.

Ijiri N, Kanazawa H, Yoshikawa T, Hirata K.

Int J Chron Obstruct Pulmon Dis. 2014 Nov 3;9:1235-40. doi: 10.2147/COPD.S71383. eCollection 2014.

13.

Low FEV1, smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort.

Vold ML, Aasebø U, Melbye H.

Int J Chron Obstruct Pulmon Dis. 2014 Oct 21;9:1225-33. doi: 10.2147/COPD.S69438. eCollection 2014.

14.

Characteristics of undiagnosed COPD in a senior community center.

Santos SR, Lizzi ES, Vianna EO.

Int J Chron Obstruct Pulmon Dis. 2014 Oct 15;9:1155-61. doi: 10.2147/COPD.S49521. eCollection 2014.

15.

Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.

Bade G, Khan MA, Srivastava AK, Khare P, Solaiappan KK, Guleria R, Palaniyar N, Talwar A.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 5;9:759-73. doi: 10.2147/COPD.S61347. eCollection 2014.

16.

Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.

Kitaguchi Y, Fujimoto K, Hanaoka M, Honda T, Hotta J, Hirayama J.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 29;9:805-11. doi: 10.2147/COPD.S65621. eCollection 2014.

17.

Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.

de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 29;9:735-43. doi: 10.2147/COPD.S64135. eCollection 2014.

18.

Characteristics and self-rated health of overlap syndrome.

Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 21;9:795-804. doi: 10.2147/COPD.S61093. eCollection 2014.

19.

Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan.

Al Omari M, Khassawneh BY, Khader Y, Dauod AS, Bergus G.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 17;9:753-8. doi: 10.2147/COPD.S62898. eCollection 2014.

20.

Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.

Donohue JF, Herje N, Crater G, Rickard K.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 16;9:745-51. doi: 10.2147/COPD.S44552. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk